CNB Bank’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $246K | Sell |
1,945
-5
| -0.3% | -$659 | 0.1% | 140 |
|
|
2026
Q1 | $272K | Sell |
1,950
-138
| -7% | -$19.3K | 0.11% | 132 |
|
|
2025
Q4 | $256K | Buy |
2,088
+58
| +3% | +$7.05K | 0.1% | 135 |
|
|
2025
Q3 | $225K | Buy |
2,030
+1,448
| +249% | +$165K | 0.09% | 143 |
|
|
2025
Q2 | $64.5K | Hold |
582
| – | – | 0.03% | 222 |
|
|
2025
Q1 | $65.2K | Hold |
582
| – | – | 0.03% | 219 |
|
|
2024
Q4 | $53.8K | Hold |
582
| – | – | 0.03% | 235 |
|
|
2024
Q3 | $48.8K | Buy |
582
+3
| +0.5% | +$229 | 0.02% | 254 |
|
|
2024
Q2 | $39.7K | Hold |
579
| – | – | 0.02% | 270 |
|
|
2024
Q1 | $42.4K | Hold |
579
| – | – | 0.02% | 262 |
|
|
2023
Q4 | $46.9K | Hold |
579
| – | – | 0.03% | 249 |
|
|
2023
Q3 | $43.4K | Buy |
+579
| New | +$44.5K | 0.03% | 255 |
|
|
2023
Q2 | – | Sell |
-250
| Closed | -$20.7K | – | 456 |
|
|
2023
Q1 | $20.7K | Hold |
250
| – | – | 0.01% | 289 |
|
|
2022
Q4 | $21.5K | Hold |
250
| – | – | 0.01% | 275 |
|
|
2022
Q3 | $15K | Hold |
250
| – | – | 0.01% | 300 |
|
|
2022
Q2 | $15K | Sell |
250
-18
| -7% | -$1.11K | 0.01% | 297 |
|
|
2022
Q1 | $16K | Sell |
268
-18
| -6% | -$1.15K | 0.01% | 303 |
|
|
2021
Q4 | $21K | Hold |
286
| – | – | 0.01% | 282 |
|
|
2021
Q3 | $20K | Sell |
286
-59
| -17% | -$4.14K | 0.01% | 291 |
|
|
2021
Q2 | $24K | Buy |
345
+27
| +8% | +$1.8K | 0.02% | 281 |
|
|
2021
Q1 | $21K | Hold |
318
| – | – | 0.01% | 276 |
|
|
2020
Q4 | $19K | Buy |
318
+36
| +13% | +$2.17K | 0.01% | 280 |
|
|
2020
Q3 | $18K | Hold |
282
| – | – | 0.02% | 275 |
|
|
2020
Q2 | $22K | Hold |
282
| – | – | 0.02% | 271 |
|
|
2020
Q1 | $21K | Buy |
282
+250
| +781% | +$17.3K | 0.02% | 255 |
|
|
2019
Q4 | $2K | Hold |
32
| – | – | ﹤0.01% | 366 |
|
|
2019
Q3 | $2K | Sell |
32
-108
| -77% | -$7.06K | ﹤0.01% | 369 |
|
|
2019
Q2 | $9K | Buy |
140
+108
| +338% | +$7.11K | 0.01% | 367 |
|
|
2019
Q1 | $2K | Hold |
32
| – | – | ﹤0.01% | 358 |
|
|
2018
Q4 | $2K | Hold |
32
| – | – | ﹤0.01% | 321 |
|
|
2018
Q3 | $2K | Hold |
32
| – | – | ﹤0.01% | 285 |
|
|
2018
Q2 | $2K | Buy |
+32
| New | +$2.26K | ﹤0.01% | 285 |
|
Other funds holding GILD
CNB Bank's GILD Position: Q2 2026 in Review
CNB Bank reduced its Gilead Sciences (GILD) stake by 0.26% in Q2 2026, selling an estimated $659 and leaving 1,945 shares worth $246K. The position accounts for 0.1% of the portfolio, ranked #140.
CNB Bank first reported a position in GILD in Q2 2018 and has held it in 32 quarters since. The position peaked at $272K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- CNB Bank held 1,945 shares of Gilead Sciences worth $246K as of Q2 2026.
- CNB Bank sold 5 Gilead Sciences shares in Q2 2026, an estimated $659.
- Gilead Sciences made up 0.1% of CNB Bank's portfolio in Q2 2026, its #140 holding.
- CNB Bank first reported a position in Gilead Sciences in Q2 2018 and has held it in 32 quarters since.
- CNB Bank's Gilead Sciences position peaked at $272K in Q1 2026.
- 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on CNB Bank's 13F filing for Q2 2026, filed 6 Aug 2026.